Physician profile
Sterling Smith
NPI 1134733652
$2,322.80
in general payments reported to CMS, 2019-2025
20 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $627 · 2022: $343 · 2023: $509 · 2024: $512 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,352.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $658.72 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $620.04 | 2023-2025 | General - Therapies, Watchman Flx |
| Esperion Therapeutics, INC. | $167.63 | 2021-2023 | Nexletol |
| Novartis Pharmaceuticals Corporation | $159.75 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $133.03 | 2021-2023 | Verquvo |
| Endologix LLC | $128.25 | 2025 | Torus Stent Graft System, Endocross Device |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.21 | 2021-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $79.50 | 2024 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.06 | 2021-2025 | Jardiance |
| Amarin Pharma, INC. | $42.16 | 2021 | |
| Irhythm Technologies, INC. | $29.37 | 2024 | Zio Xt Patch, Zio Monitor |
| Medicure Pharma INC. | $21.68 | 2022 | |
| Pfizer INC. | $18.66 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $18.42 | 2021 | |
| Impulse Dynamics (USA) INC. | $18.35 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.91 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.29 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $15.90 | 2021 | |
| Scpharmaceuticals INC. | $15.16 | 2025 | |
| Teleflex LLC | $13.71 | 2023 | Guideliner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sterling Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.